Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29570778 | 0.89 | DRD1 (0.46) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL5078882 | 0.89 | DRD1 (0.46) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL29699088 | 0.89 | DRD1 (0.46) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL23181343 | 0.83 | DRD1 (0.41) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL18304637 | 0.82 | DRD1 (0.40) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL29412647 | 0.82 | DRD1 (0.40) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL23174129 | 0.81 | DRD1 (0.40) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL16638799 | 0.80 | DRD1 (0.39) | DRD1NPSR1MEN1KMT2AALDH1A1 | |
| SCHEMBL29435775 | 0.78 | DRD1 (0.71) | DRD1NPSR1MEN1KMT2A | |
| SCHEMBL10154120 | 0.78 | DRD1 (0.71) | DRD1NPSR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8975385-B2 | Rare-earth complex and uses thereof | National University Corporation NARA Institute of Science and Technology (JP) | 2015-03-10 | — | — | US | disclosed |
| US-20120140439-A1 | RARE-EARTH COMPLEX AND USES THEREOF | National University Corporation NARA Institute of Science and Technology (JP) | 2012-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120140439-A1 | RARE-EARTH COMPLEX AND USES THEREOF | LUC7L2, NDUFS5, NDUFS7 | DRD1 4678/4885NPSR1 2546/4885MEN1 364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.